- Filter by
- Categories
- Tags
- Show all
- Article
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Services
- Summary
- Trade Secrets
- Trade-mark
- Validity
- 3D printing
- abandonment
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- airport security
- ambiguity
- amending
- Anticipation
- application
- arbitration
- Assignment
- Australia
- bad faith
- Bill C-43
- Bill C-8
- Biotech Patents
- book launch
- brand
- budget
- burden of proof
- calculation
- call processing
- Canada
- canadian patent law
- causal link
- cdrp
- champerty
- chemical patent
- ciba
- CIPO
- cira
- Claim Construction
- Class Actions
- combination drugs
- commissioner
- Common General Knowledge
- complete code
- Confidential Information
- confidentiality
- conflict of interest
- conflicts
- conflicts of interest
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- contract
- contributory infringement
- Copyright
- copyright infringement
- copyright test
- Costs
- counsel
- damages
- Data
- Data Protection
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- design patents
- designs
- deviation
- digital infringement
- disclosure
- distinctiveness
- diversity
- division of powers
- DNA Patents
- domain
- domain names
- dosage range
- Double Patenting
- doubtful cases
- e-commerce
- errors
- essentiality of elements
- Ethics
- Europe
- Evidence
- examination quality
- examination statistics
- expert blinding
- expert evidence
- Experts
- Expungement
- extraterritoriality
- federal court
- federal court of appeal
- fee
- fees
- file wrapper
- filing
- financial services
- foreign issue estoppel
- forum selection
- Free World Trust
- funding
- future infringement
- generics
- global
- Good Faith
- government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- ICSID
- Illegality
- Improver
- Indefiniteness
- industrial designs
- infringement
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- intellectual property
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP
- IP management
- ip regime
- IP Strategy
- IPO
- IT patent
- ITC
- Jurisdiction
- law
- law firm
- Legal Retainer
- legitimate interest
- license
- licensee
- Licensing
- limitation periods
- litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- Methods of Medical Treatment
- minister of health
- minorities
- misleading
- monopoly
- motion
- NAFTA
- no chance of success
- non-infringing alternative
- non-statutory subject matter
- notice of allegation
- notice to rectify
- novelty
- obvious to try
- Obviousness
- on-sale bar
- Online
- ontario
- outsourcing
- Overbreadth
- overpromising
- ownership
- Ownership & Inventorship
- Passing Off
- Patent
- patent act
- Patent Agents
- patent appeal board
- patent application
- patent book
- patent eligibility
- patent infrigement
- patent infringement
- patent law
- patent litigation
- Patent Office
- patent ownership
- patent rules
- Patent Strategy
- patent trolls
- Patentable Subject Matter
- patented medicines
- patented medicines prices review board
- patentee
- patents
- PCT
- pharma
- pharmaceutical
- pharmaceutical pricing
- PM(NOC)
- PM(NOC) Damages
- PMPRB
- price regulation
- prices
- prior disclosure
- prior disclosure defence
- priority
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- Promise
- promise doctrine
- proprietor
- prosecution
- prothonotaries
- provisional patent
- Public Servant
- Punitive Damages
- quantification
- ramped-up sales
- Records
- relevant date for construction
- remedies
- requisition
- responding
- Royalties
- SCOTUS
- second person
- Secondary Infringement
- section 101
- section 28
- Section 45
- Section 52
- section 56
- section 7
- security
- selection patents
- Services
- settlement
- skilled person
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- springboard profits
- SRED
- Standard of Review
- standing
- Startups
- statute of monopolies
- statutory subject matter
- subject matter
- Sufficiency
- Summary Judgment
- summary trial
- supreme court
- swiss
- tadalafil
- TPP
- trade secrets
- trade-mark
- Trade-mark Infringement
- Trade-mark Licensing
- Trade-mark Use
- trade-marks act
- trademark
- trademarks
- Trademarks use
- treaty
- UK
- United States
- unpatentable
- untrue material allegation
- US
- useful article
- USPTO
- Utility
- validity
- Varying records
- wenger
- women
March 3, 2015
March 3, 2015
Alcon Canada Inc v Cobalt Pharmaceuticals Company, 2014 FC 149 - The Court examined in detail a number of experiments disclosed in the patent that were said to establish the claimed utility, but the experiments did not demonstrate or soundly predict utility for the broad ranges of molecular weight and chemical concentration claimed.
February 25, 2015
February 25, 2015
Eli Lilly Canada v Canada (Attorney General), 2014 FC 152 - This decision clearly states that a higher level of specificity is required to adhere to the Regulations than is required for an element to be claimed as a matter of claim construction.
February 23, 2015
February 23, 2015
Teva Pharmaceuticals USA, Inc, et al v Sandoz, Inc, et al, 574 US __ (2015) - United States Supreme Court clarified that claim construction can involve subsidiary factual disputes that are reviewed on a clear error standard, while the ultimate question of claim construction is reviewed de novo.